31 public sources
A nightly pipeline checks for updates; refresh schedules and coverage vary by source. Anything missing from the stored data is fetched live from PubMed, DailyMed and ClinicalTrials.gov.
| Family | Datasets | What it adds | Coverage |
|---|---|---|---|
| FDA adverse-event reports | FAERS | FDA’s database of reported side effects. | From 2004, with its predecessor AERS |
| Labels and approvals | DailyMed label history; Drugs@FDA; Orange Book | Each label version, who holds the application, and the approved products. | Orange Book editions from 1985 |
| FDA reviews and actions | Safety label changes; safety communications; warning letters; advisory committees; approval reviews; citizen petitions; guidance | What FDA reviewed, said and decided. | |
| Regulations and statutes | eCFR; US Code; Federal Register | The rules as they read on a given date: 21 CFR by date (annual editions before December 2016), the current US Code. | |
| Studies and trials | PubMed (searched live for each drug); ClinicalTrials.gov | Published studies and trial results. | |
| Regulators abroad | EMA; MHRA; Health Canada; Swissmedic; Canada Vigilance | Warnings and reports from outside the US. | |
| Devices | MAUDE; 510(k); PMA; recalls; GUDID | Device reports, clearances, approvals and recalls. | |
| Company and prescribing | SEC filings; Medicare Part D; Medicaid | The company behind a product, and how widely it is prescribed. | |
| Courts | Court opinions; state product-liability statutes | Federal and state court decisions; the current product-liability statutes of Texas, Michigan, New Jersey and Louisiana. | |
| Names | RxNorm; ATC; links between them | One drug under every brand, generic and company name, and side effects matched across medical vocabularies. |
Dates, and when each became public
Each item says whether its date is published, submitted or approved, and when it became public. The methodology sets out the limits of each source family.